ARS Pharmaceuticals, Inc. Public Float
ARS Pharmaceuticals, Inc. (SPRY) had Public Float of $1.09 billion as of 2025-06-30, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-09
- 2025-06-30: Entity Public Float $1.09B.
- 2024-06-28: Entity Public Float $466.10M.
- 2023-06-30: Entity Public Float $381.80M.
- 2022-06-30: Entity Public Float $102.90M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.09B 10-K · filed 2026-03-09 |
| 2024-06-28 | $466.10M 10-K · filed 2025-03-20 |
| 2023-06-30 | $381.80M 10-K · filed 2024-03-21 |
| 2022-06-30 | $102.90M 10-K · filed 2023-03-23 |
| 2021-06-30 | $676.80M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |